Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users: A Comprehensive Review of the International Evidence

References

• Abdala N., Stephens P. C., Griffith B. P., Heimer R. Survival of HIV-1 in syringes. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1999; 20: 73–80, [CSA]
   PubMedGoogle Scholar
• Bastos F. I., Strathdee S. A. Evaluating effectiveness of syringe exchange programes: current issues and future prospects. Social Science & Medicine 2000; 51: 1771–1782, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bluthenthal R. N., Gogineni A., Longshore D., Stein M. Factors associated with readiness to change drug use among needle-exchange users. Drug & Alcohol Dependence 2001; 62: 225–230, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bluthenthal R. N., Kral A. H., Erringer E. A., Edlin B. R. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 18: 505–511, [CSA]
   PubMedGoogle Scholar
• Bluthenthal R. N., Kral A. H., Gee L., Erringer E. A., Edlin B. R. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 2000; 14: 605–611, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bradford Hill A. The environment and disease: association or causation. Procedures of the Royal Society of Medicine 1965; 58: 295–300, [CSA]
   PubMed Web of Science ®Google Scholar
• Broadhead R. S., van Hulst Y., Heckathorn D. D. The impact of a needle exchange's closure. Public Health Reports 1999; 114: 439–447, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bruneau J., Lamothe F., Franco E., Lachance N., Désy M., Soto J., Vinclette J. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. American Journal of Epidemiology 1997; 146: 994–1002, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Buchanan D., Shaw S., Ford A., Singer M. Empirical science meets moral panic: an analysis of the politics of needle exchange. Journal of Public Health Policy 2003; 24: 427–444, [CSA]
   PubMed Web of Science ®Google Scholar
• Burns S. M., Brettle R. P., Gore S. M., Peutherer J. F., Robertson J. R. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. Journal of Infection 1996; 32: 53–62, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chitwood D. D., McCoy C. B., Inciardi J. A., McBride D. C., Comerford M., Trapido E., McCoy H. V., Page J. B., Griffin J., Fletcher M. A., Ashman M. A. HIV seropositivity of needles from shooting galleries in South Florida. American Journal of Public Health 1990; 80: 150–152, [CSA]
   PubMed Web of Science ®Google Scholar
• Chitwood D. D., Griffin D. K., Comerford M., Page J. B., Trapido E. J., Lai S., McCoy C. B. Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. American Journal of Public Health 1995; 85: 1538–1542, [CSA]
   PubMed Web of Science ®Google Scholar
• Coutinho R. A. HIV and hepatitis C among injecting drug users: success in preventing HIV has not been mirrored for hepatitis C. British Medical Journal 1998; 317: 424–425, [PUBMED], [CSA]
   PubMedGoogle Scholar
• Coutinho R. A. Needle exchange, pragmatism, and moralism [letter;comment]. American Journal of Public Health 2000; 90: 1385–1387, [CSA]
   PubMed Web of Science ®Google Scholar
• Cox G. M., Lawless M. C., Cassin S. P., Geoghegan T. W. Syringe exchanges: a public health response to problem drug use. Irish Medical Journal 2000; 93: 143–146, [CSA]
   PubMedGoogle Scholar
• Crofts N., Aitken C. K., Kaldor M. J. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia 1999; 170: 220–221, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Friedman S. R., Sotheran J. L., Wenston J., Marmor M., Yancovitz S. R., Frank B., Beatrice S., Mildvan D. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA 1994; 271: 121–127, [PUBMED], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R., Friedmann P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., Wodak A. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995; 274: 1226–1231, [PUBMED], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., Jose B., Friedman S. R. HIV incidence among injecting drug users in New York City syringe-exchange programmes. The Lancet 1996; 348: 987–991, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Perlis T., Friedman S., Chapman T., Kwok J., Rockwell R., Paone D., Milliken J., Monterroso E. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990–1997. American Journal of Public Health 2000; 90: 1112–1116, [CSA]
   PubMed Web of Science ®Google Scholar
• Doherty M. C., Junge B., Rathouz P., Garfein R. S., Riley E., Vlahov D. The effect of needle exchange program on numbers of discarded needles: a 2-year follow-up. American Journal of Public Health 2002; 90: 936–939, [CSA]
   Web of Science ®Google Scholar
• Dolan K., Rutter S., Wodak A. D. Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003; 98: 153–158, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dolan K., Wodak A., Hall W., Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug & Alcohol Dependence 1998; 50: 197–202, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Donoghoe M. C., Dolan K., Stimdon G. V. Life-style factors and social circumstances of syringe sharing in injecting drug users. British Journal of Addiction 1992; 87: 993–1003, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Donoghoe M. C., Stimson G. V., Dolan K., Alldritt L. Changes in HIV risk behaviour in clients of syringe-exchanges schemes in England and Scotland. AIDS 1989; 15: 267–272, [CSA]
   Google Scholar
• Fennema J. S. A., van Ameijden E. J. C., van den Hoek A., Coutinho R. A. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997; 92: 1457–1466, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Frischer M., Elliot L. Discriminating needle exchange attender from non-attenders. Addiction 1993; 88: 681–687, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• General Accounting Office. Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. U.S. Government Printing Office, Washington, DC 1993
   Google Scholar
• Gibson D. R. Two- to sevenfold decreased risk associated with use of needle exchange. Paper presented at University of California 3rd annual Conference on AIDS Research in California, 17th Annual AIDS investigators' Meeting. University of California, South San Francisco, California 2000
   Google Scholar
• Gibson D. R., Brand R., Anderson K., Kahn J. G., Perales D., Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiency Syndromes 2002; 31: 237–242, [CSA]
   PubMed Web of Science ®Google Scholar
• Gibson D. R., Flynn N. M. Some Observations Concerning the Contrary Evidence of Syringe Exchange Effectiveness. University of California : AIDS Research Institute, San Francisco 2001
   Google Scholar
• Gibson D. R., Flynn N. M. Some Observations Concerning the Contrary Evidence of Syringe Exchange Effectiveness. AIDS Research Institute, University of California, San Francisco, Barcelona 2001
   Google Scholar
• Gibson D. R., Flynn N. M., Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001; 15: 1329–1341, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gleghorn A. A., Jones T. S., Doherty M. C., Celentano D. D., Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1995; 10: 97–103, [CSA]
   PubMedGoogle Scholar
• Gleghorn A. A., Wright-De Aguero L., Flynn C. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States Metropolitan areas. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 18: S30–S36, [CSA]
   Google Scholar
• Gold M., Gafni A., Nelligan P., Millson P. Needle exchange programs: an economic evaluation of a local experience. Canadian Medical Association Journal 1997; 157: 255–262, [PUBMED], [CSA]
   Web of Science ®Google Scholar
• Gray J. Operating needle exchange programmes in the hills of Thailand. AIDS Care 1995; 7: 489–499, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Guydish J., Bucardo J., Clark G., Bernheim S. Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Substance Use & Misuse 1998; 33: 1173–1196, [CSA]
   PubMed Web of Science ®Google Scholar
• Guydish J., Bucardo J., Young M., Woods W., Grinstead O. Eualuating needle exchange: are there negative effects? AIDS 1993; 7: 871–876, [CSA]
   Google Scholar
• Guydish J., Clark G., Garcia D., Bucardo J. Evaluation of needle exchange using street-based survey methods. Journal of Drug Issues 1995; 25: 33–41, [CSA]
   Web of Science ®Google Scholar
• Hagan H., Des Jarlais D. C., Friedman S. R., Purchase D., Alter M. J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health 1995; 85: 531–537, [CSA]
   Web of Science ®Google Scholar
• Hagan H., McGough J. P., Thiede H., Hopkins S., Duchin J., Alexander E. R. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 2000; 19: 247–252, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hartgers C., Buning E. C., van Santen G. W., Verster A. D., Coutinho R. A. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS 1989; 3: 571–576, [CSA]
   PubMed Web of Science ®Google Scholar
• Hartgers C., van Ameijden E. J., van den Hoek J. A., Coutinho R. A. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting users. Public Health Reports 1992; 107: 675–681, [CSA]
   PubMed Web of Science ®Google Scholar
• Health Outcomes International (HOI), NDARC, Drummond M. Return on Investment in Needle and Syringe Programs in Australia. Commonwealth Department of Health and Ageing, Canberra 2002
   Google Scholar
• Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment?. Journal of Substance Abuse Treatment 1998; 15: 183–191, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Heimer R., Kaplan E. H., Khoshnood K., Jariwala B., Cadman E. C. Needle exchange decreases the prevalence of HIV-1 Proviral DNA in returned syringes in New Haven, Connecticut. The American Journal of Medicine 1993; 95: 214–220, [PUBMED], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Heimer R., Khoshnood K., Bigg D., Guydish J., Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 18: S37–S44, [CSA]
   PubMedGoogle Scholar
• Holtgrave D. R., Pinkerton S. D., Jones T. S., Lurie P., Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 18: S133–S138, [CSA]
   PubMedGoogle Scholar
• Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet 1997; 349: 1797–1800, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Inciardi J. A., Page J. B., McBride D. C., Chitwood D. D., McCoy C. B., McCoy H. V., Trapedo E. J. The risk of exposure to HIV-contaminated needles in shooting galleries. The American Drug Scene, J. A. Inciardi, K. McElrath. Roxbury Press, Los Angeles 1994
   Google Scholar
• Institute of Medicine of the National Academy of Science. No Time to Lose: Getting More from HIV Prevention. National Academies Press, Washington, DC 2001
   Google Scholar
• International Narcotics Control Board. Report of the International Narcotics Control Board for 2003. International Narcotics Control Board, Vienna 2004
   Google Scholar
• Jacobs P., Calder P., Taylor M., Houston S., Saunders L. D., Albert T. Cost effectiveness of Streetworks' needle exchange program of Edmonton. Canadian Medical Association Journal 1999; 90: 168–171, [CSA]
   Google Scholar
• Jenkins C., Rahman H., Saidel T., Jana S., Hussain A. M. Z. Measuring the impact of needle exchange programs among injecting drug users through the National Behavioural Surveillance in Bangladesh. AIDS Education & Prevention 2001; 13: 452–461, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Junge B., Valente T., Latkin C., Riley E., Vlahov D. Syringe exchange not associated with social network formation: results from Baltimore. AIDS 2000; 14: 423–426, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kahn J., Haynes Sanstad K. C. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS & Public Policy Journal 1997; 12: 21–30, [CSA]
   PubMedGoogle Scholar
• Kahn J. G. Economic evaluation of primary HIV prevention in injection drug users. Handbook of Economic Evaluation HIV Prevention Programs. Plenum Press, New York 1998
   Google Scholar
• Kahn J. G., Washington A. E., Showstack J. A. Updated Estimates of the Impact and Cost of HIV Prevention in Injection Drug Users. Prepared for the Centers for Disease Control. Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, San Francisco 1992
   Google Scholar
• Kahn J. G., DeCarlo P. Is HIV Prevention a Good Investment?. Infact sheet San Francisco CA: Center for AIDS Prevention Studies (CAPS), University of California, San Francisco 1995
   Google Scholar
• Kaplan E. H., Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. Journal of Acquired Immune Deficiency Syndromes 1995; 10: 175–176, [CSA]
   Web of Science ®Google Scholar
• Kaplan E. H., Khoshnood K., Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?. American Journal of Public Health 1994; 84: 1991–1994, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Kaplan E. H.E. Evaluating needle exchange programs via syringe tracking and testing. AIDS and Public Policy 1991; 6: 109–115, [CSA]
   Google Scholar
• Keene J., Stimson G. V., Jones S., Parry-Langdon N. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. Addiction 1993; 88: 1063–1070, [CSA]
   PubMed Web of Science ®Google Scholar
• Klee H., Faugier J., Hayes C., Morris J. The sharing of injection equipment among drug users attending prescribing clinics and those using needle exchange. British Journal of Addiction 1991; 86: 217–223, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Klee H., Morris J. The role of needle exchanges in modifying sharing behaviour: cross-study comparisons 1989–1993. Addiction 1995; 90: 1635–1645, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kumaranayake L., Vickerman P., Walker D., Samoshkin S., Romantzov V., Emelyanova Z., Zviagin V., Watts C. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction 2004; 99: 1565–1576, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kumaranayake L. V., Walker P., Samoshkin D., Romantzov V., Emelyanova Z., Zviagin V., Watts C. The Cost-Effectiveness of HIV Preventive Measures Among Injecting Drug Users in Svetlogorsk, Belarus: Addiction 2004; 99: 1565–1571, [CSA]
   Google Scholar
• Latkin C. A., Forman V. L. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 2001; 27: 398–404, [CSA]
   Google Scholar
• Laufer F. N. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes 2001; 28: 273–278, [CSA]
   PubMed Web of Science ®Google Scholar
• Lima E. S., Friedman S. R., Bastos F. I., Telles P. R., Friedmann P., Ward T. P., des Jarlais D. C. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment in Rio de Janeiro. Addiction 1994; 89: 689–698, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ljungberg B., Christensson B., Tunving K., Andersson B., Landvall B., Lundberg M., Zall-Friberg A. C. HIV prevention among injecting drug users: three years of experience from a syringe exchange program in Sweden. Journal of Acquired Immune Deficiency Syndromes 1991; 4: 890–895, [CSA]
   PubMed Web of Science ®Google Scholar
• Lowndes C. M., Alary M. Re: High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study [letter]. American Journal of Epidemiology 1998; 148: 713–714, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Lurie P., Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. The Lancet 1997; 349: 604–608, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lurie P., Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. The Lancet 1997; 349: 604–608, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lurie P., Gorsky R., Jones S. T., Shomphe L. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 18: S126–S132, [CSA]
   Google Scholar
• Lurie P., Reingold A. L., eds. The Public Health Impact of Needle Exchange Programs in the United States and Abroad., Vol. 1, P. Lurie, A. L. Reingold. Centers for Disease Control and Prevention, Atlanta, GA 1993; Vol. 1
   Google Scholar
• MacCoun R. J., Reuter P. Drug War Heresies: Learning from Other Vices, Times, and Places. Cambridge University Press, London 2001
   Google Scholar
• McAllister W. B. Drug Diplomacy in the Twentieth Century: An International History. Routledge, London 2000
   Google Scholar
• McCoy C. B., Shapshak P., Metsch L. R., Rivers J. E., McCoy H. V., Weatherby N. L., Shah S. M., Chitwood D. D. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. Arch Immunol Ther Exp 1995b; 43: 1–9, [CSA]
   PubMedGoogle Scholar
• McCoy C. B., Shapshak P., Shah S. M., McCoy H. V., Rivers J. E., Page J. B., Chitwood D. D., Weatherby N., Inciardi J. A., McBride D. C., Mash D. C., Watters J. K. HIV-1 prevention: interdisciplinary studies and reviews on efficacy of bleach and compliance to bleach prevention protocols. Paper presented at Workshop on Needle Exchange and Bleach Distribution Programs, Washington, DC, 1995a
   Google Scholar
• McCoy A. W. The Politics of Heroin: CIA Complicity in the Global Drug Trade. Lawrence Hill Books, Chicago, IL 2003
   Google Scholar
• Monterroso E. R., Hamburger M. E., Vlahov D., Des Jarlais D. C., Ouellet L. J., Altice F. L., Byers R. H., Kerndt P. R., Watters J. K., Bowser B. P., Fernando M. D., Holmberg S. D. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 2000; 25: 63–70, [CSA], [CROSSREF]
   Google Scholar
• National Commission on AIDS. The Twin Epidemics of Substance Use and HIV. Washington, DC 1991
   Google Scholar
• National Institutes of Health Consensus Panel. Interventions to Prevent HIV Risk Behaviors. NIH, Bethesda, MD 1997
   Google Scholar
• Nelles J., Harding T. Preventing HIV transmission in prison: a tale of medical disobedience and Swiss pragmatism. The Lancet 1995; 346: 1507–1508, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nelson K. E., Celentano D. D., Eiumtrakol S., Hoover D. R., Beyrer C., Suprasert S., Kuntolbutra S., Khamboonruang C. Changes in sexual behaviour and a decline in HIV infection among young men in Thailand. The New England Journal of Medicine 1996; 335: 297–303, [PUBMED], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nelson K. E., Vlahov D., Cohn S., Lindsay A., Solomon L., Anthony J. C. Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA 1991; 266: 2259–2261, [PUBMED], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Normand J., Valhov D., Moses L. E., eds. Preventing HIV Transmission The Role of Sterile Needles and Bleach, J. Normand, D. Vlahov. National Academy Press, Washington, DC 1995
   Google Scholar
• Oliver K. J., Friedman S. R., Maynard H., Magnuson L., Des Jarlais D. C. Impact of a needle exchange program on potentially infectious syringes in public places. Journal of Acquired Immune Deficiency Syndromes 1992; 5: 534–535, [CSA]
   PubMed Web of Science ®Google Scholar
• Oliver K. J., Maynard H., Friedman S. R., Des Jarlais D. C. Behavioral and community impact of the Portland syringe exchange program. Proceedings: Workshop on Needle Exchange and Bleach Distribution Programs, J. Normand, D. Vlahov, L. E. Moses. National Academy Press, Washington, DC 1994; 35–46
   Google Scholar
• Page J. B., Chitwood D. D., Smith P. C., Kane N., McBride D. C. Intravenous drug use and HIV infection in Miami. Medical Anthropology 1990; 4: 56–71, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Paone D., Cooper H., Alperen J., Shi Q., Des Jarlais D. C. HIV risk behaviors of current sex workers attending syringe exchange: The experiences of women in five US cities. AIDS Care 1999; 11: 269–280, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Paone D., Des Jarlais D. C., Caloir S., Friedman P. B., Ness I., Friedman S. R. (1994) New York City syringe exchange: an overview. Paper presented at Workshop on Needle Exchange and Bleach Distribution Programs. September, 27–281993. National Academy Press, Washington, D.C.
   Google Scholar
• Paone D., Des Jarlais D. C., Shi Q. Syringe exchange use and HIV risk reduction over time. AIDS 1998; 12: 121–123, [CSA]
   PubMed Web of Science ®Google Scholar
• Patrick D. M., Strathdee S. A., Archibald C. P., Ofner M., Craib K. J., Cornelisse P. G. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS 1997; 8: 437–445, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Peak A., Rana S., Maharjan S. H., Jolley D., Crofts N. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme. AIDS 1995; 9: 1067–1070, [CSA]
   PubMed Web of Science ®Google Scholar
• Power R., Nozhkina N. The value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS 2002; 16: 303–304, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Quan V. M., Chung A., Abdul-Quader A. S. The feasibility of a syringe-needle-exchange program in Vietnam. Substance Use & Misuse 1998; 33: 1055–1067, [CSA]
   PubMed Web of Science ®Google Scholar
• Safaeian M., Brookmayer R., Vlahov D., Latkin C., Harx M., Strathdee S. A. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. American Journal of Epidemiology 2002; 155: 169–175, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Samuels J. S., Vlahov D., Anthony J. C., Solomon L., Celentano D. D. The practice of “frontloading” among intravenous drug users: association with antibody. AIDS 1991; 5: 343–345, [CSA]
   PubMed Web of Science ®Google Scholar
• Satcher D. Evidence-Based Findings on the Efficacy of Syringe Exchange Programs: An Analysis of the Scientific Research Completed Since April 1998. Department of Health and Human Services, Washington, DC 2000
   Google Scholar
• Schechter M. T. S., Cornelisse, Peter G. A., Currie S., Patrick D. M., Rekart M. L., O'Shaughnessy, Michael V. Do needle exchange programs increase the spread of HIV among injection drug users: an investigation of the Vancouver outbreak. AIDS 1999; 13: F45–F51, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schoenbaum E. E., Hartel D. M., Gourevitch M. N. Needle exchange use among a cohort of injecting drug users. AIDS 1996; 10: 1729–1734, [CSA]
   PubMed Web of Science ®Google Scholar
• Sears C., Guydish J. R., Weltzien E. K., Lum P. J. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 2001; 27: 193–201, [CSA]
   Google Scholar
• Shah S. M., Shapshak P., Rivers J. E., Stewart R. V., Weatherby N. L, Xin K. Q., Page J. B., Chitwood D. D., Mash D. V., Vlahov D., McCoy C. B. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1996; 11: 301–306, [CSA]
   PubMedGoogle Scholar
• Shapshak P., Fujimura R. K., Page J. B., Segal D., Rivers J. E., Yang J., Shah S. M., Graham G., Metsch L., Weatherby N., Chitwood D. D., McCoy C. B. HIV-1. RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. Drug & Alcohol Dependence 2000; 58: 153–157, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Singer M., Himmelgreen D., Weeks M. R., Radda K. E., Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Medical Anthropology 1997; 18: 107–130, [CSA]
   PubMedGoogle Scholar
• Strathdee S. A., Celentano D. D., Shah N., Lyles C., Stambolis V. A., Macal G., Nelson K., Vlahov D. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health 1999; 76: 448–460, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S., Schechter M. T., O'Shaughnessy M. V. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11: F59–F65, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Vlahov D. The effectiveness of needle exchange programs: a review of the science and policy. AIDScience 2001; 1: 1–33, [CSA]
   Google Scholar
• Telles P. R., Bastos F. I., Guydish J., Inciardi J. A., Surratt H. L., Pearl M., Hearst N. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS 1997; 11(Suppl 1)S35–S42, [CSA]
   Google Scholar
• UNAIDS. Report on the Global HIV/AIDS Epidemic 2002. United Nations, Geneva 2002
   Google Scholar
• UNAIDS. United States of America: Country HIV and AIDS Estimates, end 2003. 2004, http://www.unaids.org/EN/geographical+area/by+country/united+states+of+america.asp (Accessed on 27 June 2005)
   Google Scholar
• UNDCP. Flexibility of Treaty Provisions as Regards Harm Reduction Approaches Legal Affairs Section. United Nations International Drug Control Programme (UNDCP), Vienna 2002
   Google Scholar
• Ungchusak K., Sriprapandh S., Pinichpongse S., Kunasol P., Thanprasertsuk S. First national sentinel seroprevalence survey of HIV-1 infection in Thailand, June 1989. Thai AIDS Journal 1989; 1: 57–74, [CSA]
   Google Scholar
• van Ameijden E. J., Coutinho R. A. Large decline in injecting drug use in Amsterdam, 1986–1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology & Community Health 2001; 55: 356–363, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van Ameijden E. J., Coutinho R. A. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS 1998; 12: 625–633, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• van Ameijden E. J., Langendam M. W., Notenboom J., Coutinho R. A. Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. Addiction 1999; 94: 1051–1061, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van Ameijden E. J., van den Hoek A. R., Coutinho R. A. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. American Journal of Public Health 1994; 84: 275–281, [CSA]
   PubMed Web of Science ®Google Scholar
• van Ameijden E. J., van den Hoek J. A. R., van Haastrecht H. J. A., Coutinho R. A. The harm reduction approach and risk factors for human immunodeficiency virus seroconversion in injecting drug users, Amsterdam. Am. J. Epidemiol 1992; 136: 236–243, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• van Haastrecht H. J., van Ameijden E. J., van den Hoek J. A., Mientjes G. H., Bax J. S., Coutinho R. A. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol 1996; 143: 380–391, [CSA]
   PubMed Web of Science ®Google Scholar
• Vickerman P., Watts C. The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: model predictions. International Journal of Drug Policy 2002; 13: 149–164, [CSA], [CROSSREF]
   Google Scholar
• Vlahov D., Junge B., Brookmeyer R., Cohn S., Riky E., Armenian H., Beilenson P. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes 1997; 16: 400–406, [CSA]
   Web of Science ®Google Scholar
• Vogt R. L., Breda M. C., Des Jarlais D. C., Gates S., Whiticar P. Hawaii's statewide syringe exchange program. American Journal of Public Health 1998; 88: 1403–1404, [CSA]
   PubMed Web of Science ®Google Scholar
• Watters J. K., Estilo M. J., Clark G. L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994; 271: 115–120, [PUBMED], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weaver H., Smith G., Kippax S. School-based sex education policies and indicators of sexual health among young people: a comparison of the Netherlands, France, Australia and the United States. Computer Science Education 2005; 5: 171–188, [CSA]
   Google Scholar
• Weber U., Schneider W. Syringe exchange in Germany. Substance Use & Misuse 1998; 33: 1093–1112, [CSA]
   PubMed Web of Science ®Google Scholar
• Wodak A., Cooney A. Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS among Injecting Drug Users. World Health Organization, Geneva 2004
   Google Scholar
• Wodak A., Dolan K., Imrie A. A., Gold J., Wolk J., Whyte B. M., Cooper D. A. Antibodies to the HIV virus in needles and syringes used by intravenous drug abusers. Medical Journal of Australia 1987; 147: 275–276, [CSA]
   PubMed Web of Science ®Google Scholar
• Wolk J., Wodak A., Guinan J. J., Macaskill P., Simpson J. M. The effect of a needle and syringe exchange on a methadone maintenance unit. British Journal of Addiction 1990; 85: 1445–1450, [CSA], [CROSSREF]
   PubMedGoogle Scholar